CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80

CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 was reported 555 times

CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DRAIN OF CEREBRAL SUBDURAL SPACE 1 0.3333
1 URINE ELECTROLYTES ABNORMAL 1 0.0625
2 INSTILLATION SITE COMPLICATION 1 0.0476
3 INTESTINAL VARICES HAEMORRHAGE 1 0.0333
4 UVEITIC GLAUCOMA 1 0.0263
5 SUBDURAL EMPYEMA 1 0.0185
6 SCLERAL HYPERAEMIA 12 0.0176
7 PSEUDOFOLLICULITIS 1 0.0159
8 WRONG PRODUCT PROCURED 1 0.0152
9 POST PROCEDURAL ERYTHEMA 1 0.0112
10 PRODUCT PRIMARY PACKAGING ISSUE 1 0.0089
11 EYELASH THICKENING 1 0.0083
12 INSTILLATION SITE DISCOMFORT 1 0.0075
13 EYE COMPLICATION ASSOCIATED WITH DEVICE 2 0.0074
14 INSTILLATION SITE FOREIGN BODY SENSATION 1 0.0069
15 ENTROPION 1 0.0065
16 EYE OPERATION COMPLICATION 1 0.0061
17 EYELID INJURY 1 0.0057
18 CATHETER SITE VESICLES 1 0.0051
19 EYELID EXFOLIATION 4 0.0051
20 FOREIGN BODY SENSATION IN EYES 31 0.0049
21 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 1 0.0042
22 EYELID PAIN 8 0.0039
23 KERATOMILEUSIS 1 0.0039
24 EYELID CYST 1 0.0039
25 EYELID OPERATION 1 0.0037
26 CATHETER SITE THROMBOSIS 1 0.0036
27 CORNEAL ABRASION 5 0.0036
28 EYELID THICKENING 1 0.0035
29 CHALAZION 2 0.0031
30 POSTERIOR CAPSULE OPACIFICATION 1 0.0029
31 INSTILLATION SITE PRURITUS 1 0.0027
32 CORNEAL TRANSPLANT 2 0.0026
33 TRI-IODOTHYRONINE INCREASED 1 0.0025
34 REACTION TO PRESERVATIVES 2 0.0025
35 EYE DISCHARGE 24 0.0023
36 CORNEAL DISORDER 5 0.0023
37 VULVOVAGINAL RASH 1 0.0023
38 REFLUX LARYNGITIS 1 0.0023
39 EYE IRRITATION 130 0.0023
40 RETINAL SCAR 1 0.0022
41 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 1 0.0021
42 FOREIGN BODY IN EYE 2 0.0021
43 INSTILLATION SITE PAIN 5 0.0020
44 EYELID IRRITATION 5 0.0020
45 CATARACT OPERATION COMPLICATION 1 0.0020
46 OCULAR DISCOMFORT 20 0.0018
47 EYE OPERATION 8 0.0017
48 METAL POISONING 1 0.0017
49 LACRIMAL DISORDER 1 0.0017
50 PRURITUS ALLERGIC 2 0.0017
51 EYE BURNS 1 0.0017
52 EYE LASER SURGERY 1 0.0017
53 INSTILLATION SITE IRRITATION 2 0.0017
54 HAEMORRHAGIC DIATHESIS 6 0.0017
55 POST PROCEDURAL INFLAMMATION 1 0.0016
56 EYELIDS PRURITUS 5 0.0016
57 STOMA SITE INFECTION 2 0.0015
58 ERYTHEMA OF EYELID 8 0.0015
59 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 2 0.0014
60 FACIAL DISCOMFORT 1 0.0014
61 ABNORMAL SENSATION IN EYE 6 0.0014
62 LIQUID PRODUCT PHYSICAL ISSUE 10 0.0014
63 FIBROCYSTIC BREAST DISEASE 1 0.0014
64 EXCESSIVE EYE BLINKING 2 0.0014
65 EYE PAIN 76 0.0013
66 ARTHRITIS INFECTIVE 6 0.0013
67 PRODUCT DROPPER ISSUE 1 0.0013
68 GROWTH OF EYELASHES 1 0.0013
69 OCULAR VASCULAR DISORDER 1 0.0012
70 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
71 MEDICAL PROCEDURE 2 0.0012
72 DYSPHORIA 6 0.0012
73 PRODUCT COLOUR ISSUE 6 0.0012
74 FOOD REFUSAL 1 0.0011
75 PUNCTATE KERATITIS 1 0.0011
76 MACULAR DEGENERATION 13 0.0011
77 HYPERMETROPIA 1 0.0011
78 SKIN WARM 6 0.0010
79 EYELID RASH 1 0.0010
80 DUST ALLERGY 1 0.0010
81 MASTOIDITIS 1 0.0010
82 PHOTOPHOBIA 19 0.0010
83 HEMIANOPIA 1 0.0010
84 DRY EYE 50 0.0010
85 STOMA COMPLICATION 1 0.0010
86 BENIGN BREAST NEOPLASM 1 0.0010
87 STEROID WITHDRAWAL SYNDROME 1 0.0010
88 HYDROCELE 1 0.0009
89 PRODUCT NAME CONFUSION 1 0.0009
90 SUPERFICIAL INJURY OF EYE 1 0.0009
91 POST PROCEDURAL SWELLING 1 0.0009
92 APPETITE DISORDER 6 0.0009
93 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
94 HALO VISION 1 0.0009
95 OPTIC NERVE INJURY 1 0.0009
96 OCULAR HYPERAEMIA 40 0.0008
97 CATARACT 50 0.0008
98 EYE INFLAMMATION 8 0.0008
99 INCORRECT PRODUCT STORAGE 11 0.0008
100 PRODUCT CONTAINER ISSUE 7 0.0008
101 ALLERGY TO CHEMICALS 1 0.0008
102 NASAL PRURITUS 1 0.0008
103 LACRIMATION INCREASED 24 0.0008
104 DACRYOSTENOSIS ACQUIRED 1 0.0008
105 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
106 MACULAR HOLE 1 0.0007
107 SKIN DEPIGMENTATION 1 0.0007
108 CALCULUS BLADDER 1 0.0007
109 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
110 AUDITORY DISORDER 1 0.0007
111 EYELID MARGIN CRUSTING 2 0.0007
112 STOMA SITE PAIN 1 0.0007
113 APRAXIA 1 0.0007
114 ASTIGMATISM 1 0.0007
115 EYE INJURY 2 0.0007
116 STOMA SITE HAEMORRHAGE 1 0.0006
117 MEDICAL DEVICE IMPLANTATION 1 0.0006
118 PHOTOPSIA 4 0.0006
119 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
120 CYSTITIS INTERSTITIAL 1 0.0006
121 VITREOUS FLOATERS 6 0.0006
122 EYELID PTOSIS 6 0.0006
123 PRODUCT LABEL ISSUE 4 0.0006
124 MEDICAL DEVICE REMOVAL 1 0.0006
125 TENDERNESS 6 0.0006
126 SPINAL CORD INJURY 1 0.0006
127 BREAST CYST 1 0.0006
128 OPHTHALMIC HERPES ZOSTER 1 0.0006
129 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
130 STOMA SITE ERYTHEMA 1 0.0005
131 MULTIPLE USE OF SINGLE-USE PRODUCT 3 0.0005
132 TRAUMATIC HAEMORRHAGE 1 0.0005
133 RETINAL OEDEMA 1 0.0005
134 EYE DISORDER 17 0.0005
135 REHABILITATION THERAPY 2 0.0005
136 EYELID OEDEMA 6 0.0005
137 EYE PRURITUS 17 0.0005
138 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
139 BLEPHARITIS 2 0.0005
140 DEVICE CONNECTION ISSUE 1 0.0005
141 GLAUCOMA 9 0.0005
142 HORDEOLUM 2 0.0005
143 VITREOUS DETACHMENT 1 0.0005
144 EYE INFECTION 5 0.0004
145 RETINAL DETACHMENT 4 0.0004
146 EYELID DISORDER 1 0.0004
147 SINUS PAIN 1 0.0004
148 VISION BLURRED 58 0.0004
149 TRANSPLANT 1 0.0004
150 MEDICATION RESIDUE PRESENT 2 0.0004
151 EAR PAIN 8 0.0004
152 RETINAL TEAR 1 0.0004
153 RETINAL DISORDER 1 0.0004
154 EXFOLIATIVE RASH 1 0.0004
155 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
156 THINKING ABNORMAL 7 0.0004
157 MIGRAINE WITH AURA 1 0.0004
158 SUBDURAL HAEMORRHAGE 1 0.0004
159 STOMA SITE DISCHARGE 1 0.0004
160 RHINALGIA 1 0.0004
161 THYROID NEOPLASM 1 0.0004
162 SNEEZING 8 0.0004
163 PERIORBITAL SWELLING 2 0.0004
164 LIP PAIN 1 0.0003
165 RETINAL VEIN OCCLUSION 1 0.0003
166 STRABISMUS 1 0.0003
167 PORTAL HYPERTENSION 1 0.0003
168 SWELLING OF EYELID 2 0.0003
169 PRODUCT USE COMPLAINT 5 0.0003
170 ORAL PAIN 7 0.0003
171 HOSPICE CARE 3 0.0003
172 VISUAL ACUITY REDUCED 10 0.0003
173 EMPHYSEMA 3 0.0003
174 POLYMENORRHOEA 1 0.0003
175 BLINDNESS UNILATERAL 4 0.0003
176 BLINDNESS TRANSIENT 2 0.0003
177 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
178 CLAVICLE FRACTURE 1 0.0003
179 MUSCLE RUPTURE 1 0.0003
180 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
181 EYE HAEMORRHAGE 3 0.0002
182 RHINITIS ALLERGIC 1 0.0002
183 ABDOMINAL HERNIA 1 0.0002
184 EYE SWELLING 8 0.0002
185 WOUND 6 0.0002
186 SKIN TIGHTNESS 1 0.0002
187 VAGINAL INFECTION 1 0.0002
188 EXPIRED PRODUCT ADMINISTERED 7 0.0002
189 PRODUCT PACKAGING ISSUE 2 0.0002
190 VISUAL IMPAIRMENT 26 0.0002
191 COELIAC DISEASE 2 0.0002
192 NASAL POLYPS 1 0.0002
193 EXPIRED DRUG ADMINISTERED 1 0.0002
194 INJECTION SITE INFLAMMATION 1 0.0002
195 VULVOVAGINAL PRURITUS 1 0.0002
196 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
197 BLINDNESS 8 0.0002
198 AMMONIA INCREASED 1 0.0002
199 TRISMUS 1 0.0002
200 PRODUCT RESIDUE PRESENT 1 0.0002
201 JAW DISORDER 1 0.0002
202 ASTHENOPIA 1 0.0002
203 CHOKING SENSATION 1 0.0002
204 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
205 SKIN DISORDER 6 0.0002
206 PRODUCT LABEL CONFUSION 1 0.0002
207 CATARACT OPERATION 1 0.0002
208 TENSION 1 0.0002
209 HAIR COLOUR CHANGES 2 0.0002
210 PRE-EXISTING CONDITION IMPROVED 1 0.0002
211 INTESTINAL OBSTRUCTION 6 0.0002
212 BLEPHAROSPASM 1 0.0002
213 THERAPEUTIC RESPONSE CHANGED 1 0.0002
214 INTRAOCULAR PRESSURE INCREASED 2 0.0002
215 MYDRIASIS 2 0.0002
216 RHINORRHOEA 10 0.0002
217 POLYP 1 0.0002
218 PRODUCT PREPARATION ISSUE 1 0.0002
219 DISABILITY 3 0.0002
220 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
221 WRONG PRODUCT ADMINISTERED 1 0.0001
222 UVEITIS 2 0.0001
223 EYE MOVEMENT DISORDER 1 0.0001
224 PERIPHERAL COLDNESS 2 0.0001
225 LYMPHOEDEMA 1 0.0001
226 ENCEPHALITIS 1 0.0001
227 HAIR GROWTH ABNORMAL 1 0.0001
228 OSTEOARTHRITIS 6 0.0001
229 SEASONAL ALLERGY 2 0.0001
230 VISUAL FIELD DEFECT 1 0.0001
231 WHEEZING 8 0.0001
232 HIP ARTHROPLASTY 2 0.0001
233 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
234 PELVIC FRACTURE 1 0.0001
235 THERAPY PARTIAL RESPONDER 2 0.0001
236 ANAPHYLACTIC REACTION 7 0.0001
237 NECK PAIN 7 0.0001
238 TRANSPLANT REJECTION 1 0.0001
239 BLISTER 7 0.0001
240 INTERSTITIAL LUNG DISEASE 6 0.0001
241 PHOTOSENSITIVITY REACTION 2 0.0001
242 SECOND PRIMARY MALIGNANCY 1 0.0001
243 HEMIPLEGIA 1 0.0001
244 SENSATION OF FOREIGN BODY 1 0.0001
245 IMMUNOSUPPRESSION 1 0.0001
246 FACIAL PAIN 1 0.0001
247 OEDEMA 6 0.0001
248 EXOSTOSIS 1 0.0001
249 BRAIN NEOPLASM 1 0.0001
250 PRODUCT DISTRIBUTION ISSUE 1 0.0001
251 CONJUNCTIVITIS 2 0.0001
252 ARTERIOSCLEROSIS 1 0.0001
253 SQUAMOUS CELL CARCINOMA 1 0.0001
254 LEUKAEMIA 1 0.0001
255 INABILITY TO AFFORD MEDICATION 1 0.0001
256 PRODUCT ADMINISTRATION ERROR 2 0.0001
257 DRY THROAT 1 0.0001
258 DRY SKIN 13 0.0001
259 POOR VENOUS ACCESS 1 0.0001
260 PRODUCT ODOUR ABNORMAL 1 0.0001
261 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
262 HALLUCINATION 7 0.0001
263 SKIN LACERATION 1 0.0001
264 MALNUTRITION 1 0.0001
265 IMPAIRED DRIVING ABILITY 1 0.0001
266 PRODUCT AVAILABILITY ISSUE 2 0.0001
267 DERMATITIS CONTACT 1 0.0001
268 CHOLECYSTECTOMY 1 0.0001
269 INTERNAL HAEMORRHAGE 1 0.0001
270 DYSPHAGIA 8 0.0001
271 ACCIDENTAL OVERDOSE 3 0.0001
272 TENDON RUPTURE 1 0.0001
273 PRODUCT STORAGE ERROR 7 0.0001
274 SECRETION DISCHARGE 1 0.0001
275 PRODUCT COMPLAINT 2 0.0001
276 ROTATOR CUFF SYNDROME 1 0.0001
277 HAIR TEXTURE ABNORMAL 1 0.0001
278 HYPOAESTHESIA 11 0.0001
279 CORONARY ARTERY OCCLUSION 1 0.0001
280 CONTUSION 7 0.0001
281 DRUG INTOLERANCE 7 0.0001
282 APHONIA 1 0.0001
283 MASS 1 0.0001
284 BURNING SENSATION 5 0.0001
285 BLOOD TEST ABNORMAL 1 0.0001
286 SKIN REACTION 1 0.0001
287 PAIN IN JAW 2 0.0001
288 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
289 MUSCULOSKELETAL STIFFNESS 6 0.0001
290 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
291 COLON CANCER 1 0.0001
292 JOINT SWELLING 8 0.0001
293 THERAPEUTIC RESPONSE DECREASED 4 0.0001
294 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
295 PHARYNGEAL OEDEMA 1 0.0001
296 DEVICE RELATED INFECTION 1 0.0001
297 ANKLE FRACTURE 1 0.0001
298 BASAL CELL CARCINOMA 1 0.0001
299 ERYTHEMA 13 0.0001
300 HALLUCINATION, AUDITORY 1 0.0001
301 LOSS OF CONSCIOUSNESS 8 0.0001
302 HIP FRACTURE 2 0.0001
303 RHEUMATOID ARTHRITIS 7 0.0001
304 CHILLS 7 0.0001
305 PERICARDITIS 1 0.0001
306 HYPERSENSITIVITY 11 0.0001
307 HEMIPARESIS 1 0.0001
308 MYALGIA 10 0.0001
309 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
310 ORTHOSTATIC HYPOTENSION 1 0.0001
311 AMENORRHOEA 1 0.0001
312 HEAD DISCOMFORT 1 0.0001
313 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
314 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
315 CEREBRAL HAEMORRHAGE 2 0.0001
316 RESTLESS LEGS SYNDROME 1 0.0001
317 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
318 OROPHARYNGEAL PAIN 5 0.0001
319 DYSPNOEA EXERTIONAL 2 0.0001
320 GASTRIC ULCER 1 0.0001
321 INCORRECT DOSE ADMINISTERED 12 0.0001
322 SLEEP APNOEA SYNDROME 1 0.0001
323 GAIT DISTURBANCE 10 0.0001
324 PRODUCT QUALITY ISSUE 7 0.0001
325 HAEMORRHOIDS 1 0.0001
326 CHOKING 1 0.0001
327 ORAL HERPES 1 0.0001
328 SURGERY 3 0.0001
329 SKIN FISSURES 1 0.0001
330 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
331 FULL BLOOD COUNT DECREASED 1 0.0000
332 PRODUCT PHYSICAL ISSUE 1 0.0000
333 INJURY ASSOCIATED WITH DEVICE 1 0.0000
334 DRUG DOSE OMISSION 8 0.0000
335 ROAD TRAFFIC ACCIDENT 2 0.0000
336 DERMATITIS 1 0.0000
337 ABDOMINAL DISCOMFORT 8 0.0000
338 KNEE ARTHROPLASTY 1 0.0000
339 SKIN EXFOLIATION 4 0.0000
340 HALLUCINATION, VISUAL 1 0.0000
341 IRRITABLE BOWEL SYNDROME 1 0.0000
342 HYPOACUSIS 2 0.0000
343 SKIN CANCER 1 0.0000
344 COUGH 13 0.0000
345 PRODUCT DOSE OMISSION 3 0.0000
346 CONSTIPATION 10 0.0000
347 APPLICATION SITE PAIN 1 0.0000
348 STEVENS-JOHNSON SYNDROME 1 0.0000
349 NEOPLASM MALIGNANT 3 0.0000
350 DRUG INEFFECTIVE 59 0.0000
351 GLOSSODYNIA 1 0.0000
352 RASH PAPULAR 1 0.0000
353 PRURITUS 17 0.0000
354 BLOOD CHOLESTEROL INCREASED 2 0.0000
355 THERAPY INTERRUPTED 3 0.0000
356 PRODUCTIVE COUGH 2 0.0000
357 BLOOD PRESSURE FLUCTUATION 1 0.0000
358 LOCALISED INFECTION 1 0.0000
359 PRESYNCOPE 1 0.0000
360 NEURALGIA 1 0.0000
361 DYSGEUSIA 3 0.0000
362 HEART RATE INCREASED 4 0.0000
363 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
364 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
365 WEIGHT DECREASED 11 0.0000
366 INFLAMMATION 2 0.0000
367 UNRESPONSIVE TO STIMULI 1 0.0000
368 DIPLOPIA 1 0.0000
369 RESPIRATORY TRACT INFECTION 1 0.0000
370 DEAFNESS 1 0.0000
371 PARAESTHESIA 6 0.0000
372 GASTRITIS 1 0.0000
373 BREAST CANCER FEMALE 1 0.0000
374 FEAR 1 0.0000
375 BLOOD BILIRUBIN INCREASED 1 0.0000
376 FREQUENT BOWEL MOVEMENTS 1 0.0000
377 TREATMENT NONCOMPLIANCE 2 0.0000
378 HAEMOPTYSIS 1 0.0000
379 ASTHMA 4 0.0000
380 INTENTIONAL DOSE OMISSION 1 0.0000
381 RED BLOOD CELL COUNT DECREASED 1 0.0000
382 BALANCE DISORDER 3 0.0000
383 BACK PAIN 8 0.0000
384 PALPITATIONS 4 0.0000
385 BONE PAIN 2 0.0000
386 LABORATORY TEST ABNORMAL 1 0.0000
387 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
388 APHASIA 1 0.0000
389 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
390 CORONARY ARTERY DISEASE 1 0.0000
391 BLOOD PRESSURE INCREASED 5 0.0000
392 INJECTION SITE RASH 1 0.0000
393 DRUG ADMINISTRATION ERROR 1 0.0000
394 FEMUR FRACTURE 1 0.0000
395 HEAD INJURY 1 0.0000
396 HYPOTHYROIDISM 1 0.0000
397 HEADACHE 19 0.0000
398 DEVICE DIFFICULT TO USE 2 0.0000
399 ABDOMINAL PAIN 7 0.0000
400 VIRAL INFECTION 1 0.0000
401 URINARY RETENTION 1 0.0000
402 INJECTION SITE PRURITUS 2 0.0000
403 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
404 ASTHENIA 11 0.0000
405 GASTRIC DISORDER 1 0.0000
406 MEMORY IMPAIRMENT 4 0.0000
407 ARTHRALGIA 12 0.0000
408 NEOPLASM PROGRESSION 1 0.0000
409 RASH MACULAR 1 0.0000
410 DYSPNOEA 16 0.0000
411 DIZZINESS 14 0.0000
412 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
413 SKIN BURNING SENSATION 2 0.0000
414 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
415 DRUG EFFECT INCOMPLETE 1 0.0000
416 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
417 PANIC ATTACK 1 0.0000
418 NASOPHARYNGITIS 5 0.0000
419 INJECTION SITE MASS 1 0.0000
420 FALL 9 0.0000
421 BRONCHITIS 2 0.0000
422 DYSARTHRIA 1 0.0000
423 MUSCULAR WEAKNESS 3 0.0000
424 PAIN 16 0.0000
425 ARTHRITIS 2 0.0000
426 RASH 11 0.0000
427 PSORIATIC ARTHROPATHY 1 0.0000
428 INJECTION SITE ERYTHEMA 3 0.0000
429 INTENTIONAL PRODUCT MISUSE 2 0.0000
430 LIVER DISORDER 1 0.0000
431 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
432 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
433 THROAT IRRITATION 1 0.0000
434 THERAPY NON-RESPONDER 1 0.0000
435 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
436 NEPHROLITHIASIS 1 0.0000
437 MUSCLE SPASMS 4 0.0000
438 TINNITUS 1 0.0000
439 SKIN DISCOLOURATION 1 0.0000
440 HYPOKALAEMIA 1 0.0000
441 COGNITIVE DISORDER 1 0.0000
442 CARDIAC DISORDER 2 0.0000
443 MIGRAINE 2 0.0000
444 MULTIPLE SCLEROSIS 1 0.0000
445 HYPOGLYCAEMIA 1 0.0000
446 OFF LABEL USE 18 0.0000
447 MALAISE 9 0.0000
448 LUNG DISORDER 1 0.0000
449 SOMNOLENCE 4 0.0000
450 CELLULITIS 1 0.0000
451 FLUSHING 2 0.0000
452 FLUID RETENTION 1 0.0000
453 SINUSITIS 2 0.0000
454 HAEMOGLOBIN DECREASED 2 0.0000
455 ILLNESS 2 0.0000
456 FATIGUE 15 0.0000
457 VOMITING 9 0.0000
458 NERVOUSNESS 1 0.0000
459 NAUSEA 15 0.0000
460 HYPERTENSION 4 0.0000
461 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
462 PLATELET COUNT DECREASED 2 0.0000
463 DIARRHOEA 12 0.0000
464 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
465 MEDICATION ERROR 1 0.0000
466 OXYGEN SATURATION DECREASED 1 0.0000
467 HYPONATRAEMIA 1 0.0000
468 CEREBROVASCULAR ACCIDENT 3 0.0000
469 URINARY TRACT INFECTION 3 0.0000
470 HERPES ZOSTER 1 0.0000
471 PRODUCT SUBSTITUTION ISSUE 1 0.0000
472 SEIZURE 2 0.0000
473 NASAL CONGESTION 1 0.0000
474 PRODUCT DOSE OMISSION ISSUE 5 0.0000
475 STOMATITIS 1 0.0000
476 CONDITION AGGRAVATED 5 0.0000
477 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
478 PNEUMONIA 5 0.0000
479 SWELLING FACE 1 0.0000
480 BLOOD CREATININE INCREASED 1 0.0000
481 BLOOD PRESSURE DECREASED 1 0.0000
482 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
483 INFECTION 2 0.0000
484 EPISTAXIS 1 0.0000
485 UNEVALUABLE EVENT 1 0.0000
486 INJECTION SITE SWELLING 1 0.0000
487 PERIPHERAL SWELLING 2 0.0000
488 INJECTION SITE BRUISING 1 0.0000
489 CARDIAC FAILURE CONGESTIVE 1 0.0000
490 PROSTATE CANCER 1 0.0000
491 THROMBOSIS 1 0.0000
492 INFLUENZA LIKE ILLNESS 1 0.0000
493 URTICARIA 2 0.0000
494 PYREXIA 4 0.0000
495 COVID-19 2 0.0000
496 INSOMNIA 3 0.0000
497 TACHYCARDIA 1 0.0000
498 GASTROINTESTINAL DISORDER 1 0.0000
499 SUICIDAL IDEATION 1 0.0000
500 ADVERSE EVENT 1 0.0000
501 PRODUCT USE ISSUE 2 0.0000
502 ANAEMIA 2 0.0000
503 ATRIAL FIBRILLATION 1 0.0000
504 PAIN IN EXTREMITY 3 0.0000
505 CHEST DISCOMFORT 1 0.0000
506 ABDOMINAL DISTENSION 1 0.0000
507 HAEMORRHAGE 1 0.0000
508 INFLUENZA 1 0.0000
509 DISEASE PROGRESSION 1 0.0000
510 FEELING ABNORMAL 2 0.0000
511 OEDEMA PERIPHERAL 1 0.0000
512 DEHYDRATION 1 0.0000
513 INJECTION SITE PAIN 2 0.0000
514 HOSPITALISATION 1 0.0000
515 CONFUSIONAL STATE 1 0.0000
516 TREMOR 1 0.0000
517 ABDOMINAL PAIN UPPER 1 0.0000
518 DEATH 4 0.0000
519 WEIGHT INCREASED 1 0.0000
520 DEPRESSION 1 0.0000
521 DECREASED APPETITE 1 0.0000
522 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000